As of Dec 02
| -0.03 / -3.57%|
The 3 analysts offering 12-month price forecasts for Biocept Inc have a median target of 1.60, with a high estimate of 6.75 and a low estimate of 1.55. The median estimate represents a +97.53% increase from the last price of 0.81.
The current consensus among 3 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.